Jarno Hoekman
Affiliations: | Eindhoven University of Technology, Eindhoven, Noord-Brabant, Netherlands |
Area:
Information scince, science studiesGoogle:
"Jarno Hoekman"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Coppens DGM, Hoekman J, Bruin MLD, et al. (2020) Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries. Cytotherapy. 22: 592-600 |
| Ten Ham RMT, Hövels AM, Hoekman J, et al. (2020) What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings. Cytotherapy |
| Coppens DG, Gardarsdottir H, Bogert CAvd, et al. (2020) Publication rates and reported results in a cohort of gene- and cell-based therapy trials. Regenerative Medicine. 15: 1215-1227 |
| Ten Ham RMT, Hövels AM, Klungel OH, et al. (2020) Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection. Trends in Pharmacological Sciences |
| Kalkman S, Arentshorst M, Hoekman J, et al. (2019) In-Hospital Production of Medicines: Preparing for Disruption. Trends in Biotechnology. 38: 1045-1047 |
| Hoekman J, Boon W. (2019) Changing standards for drug approval: A longitudinal analysis of conditional marketing authorisation in the European Union. Social Science & Medicine. 222: 76-83 |
| Bloem LT, Mantel‐Teeuwisse AK, Leufkens HGM, et al. (2019) Postauthorization Changes to Specific Obligations of Conditionally Authorized Medicines in the European Union: A Retrospective Cohort Study. Clinical Pharmacology & Therapeutics. 105: 426-435 |
| Ten Ham RMT, Hoekman J, Hövels AM, et al. (2018) Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Molecular Therapy. Methods & Clinical Development. 11: 121-130 |
| Ampadu HH, Hoekman J, Arhinful D, et al. (2018) Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences Globalization and Health. 14: 109 |
| Coppens DGM, de Wilde S, Guchelaar HJ, et al. (2018) A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making. Cytotherapy |